Table of Content


Introduction
Neuroendocrine Tumors - Overview
Neuroendocrine Tumors - Therapeutics Development
Neuroendocrine Tumors - Therapeutics Assessment
Neuroendocrine Tumors - Companies Involved in Therapeutics Development
Neuroendocrine Tumors - Drug Profiles
Neuroendocrine Tumors - Dormant Projects
Neuroendocrine Tumors - Discontinued Products
Neuroendocrine Tumors - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Neuroendocrine Tumors, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Neuroendocrine Tumors, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Neuroendocrine Tumors - Pipeline by Aadi Bioscience Inc, H1 2020
Neuroendocrine Tumors - Pipeline by Advanced Accelerator Applications SA, H1 2020
Neuroendocrine Tumors - Pipeline by Akeso Inc, H1 2020
Neuroendocrine Tumors - Pipeline by AnHeart Therapeutics Inc, H1 2020
Neuroendocrine Tumors - Pipeline by Aquestive Therapeutics Inc, H1 2020
Neuroendocrine Tumors - Pipeline by Ascil Proyectos SL, H1 2020
Neuroendocrine Tumors - Pipeline by AstraZeneca Plc, H1 2020
Neuroendocrine Tumors - Pipeline by Beijing Foreland Pharma Co Ltd, H1 2020
Neuroendocrine Tumors - Pipeline by Boehringer Ingelheim International GmbH, H1 2020
Neuroendocrine Tumors - Pipeline by BriaCell Therapeutics Corp, H1 2020
Neuroendocrine Tumors - Pipeline by Bristol-Myers Squibb Co, H1 2020
Neuroendocrine Tumors - Dormant Projects, H1 2020
Neuroendocrine Tumors - Discontinued Products, H1 2020